Mod GRF 1-29 Dosage Guide

Complete guide to Mod GRF 1-29 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Typical dosing: 100-300mcg administered 2-3 times daily, usually combined with a GHRP like Ipamorelin for synergistic effects.

Administration Method

Subcutaneous injection. Best administered on empty stomach. Short half-life (~30 minutes) necessitates multiple daily doses, unlike DAC version.

Side Effects to Monitor

Flushing, headache, dizziness, and injection site reactions. Generally well-tolerated. May cause water retention.

Safety Considerations & Risks

Not FDA approved. May affect blood glucose. Long-term effects on pituitary function not fully characterized.